Report ID |
22634 |
Drug Identification Number |
02285614 |
Brand name |
ALVESCO |
Common or Proper name |
ciclesonide |
Company Name |
ASTRAZENECA CANADA INC |
Active Ingredient(s) |
CICLESONIDE |
Strength(s) |
200MCG |
Dosage form(s) |
AEROSOL, METERED DOSE |
Route of administration |
INHALATION |
Packaging size |
120 doses |
ATC code |
R03BA |
ATC description |
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage |
Disruption of the manufacture of the drug. |
Anticipated start date |
2017-10-06 |
Actual start date |
|
Estimated end date |
2017-10-20 |
Actual end date |
2017-10-02 |
Shortage status |
Avoided shortage |
Updated date |
2017-10-02 |
Company comments |
|
Health Canada comments |
|
Company contact information |
Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |